Pulsenmore Ltd(PLSM) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:12 AM ET (Korea 9/11 20:12)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.44 | Insider Own | 40.65% | Shs Outstand | 6.5M | Perf Week | -3.92% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 3.9M | Perf Month | -24.15% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 7.67% | Short Float | 0.23% | Perf Quarter | -39.8% |
| Income | -0.01B | P/S | 1.24 | EPS this Y | - | Inst Trans | 1.32% | Short Ratio | 0.01 | Perf Half Y | -46.74% |
| Sales | 0.01B | P/B | 0.98 | EPS next 5Y | - | ROA | -26.98% | Short Interest | 0.01M | Perf YTD | -74.07% |
| Book/sh | 2.49 | P/C | 0.68 | EPS past 3/5Y | 13.21% -1.94% | ROE | -48.74% | 52W High | -81.11% ($12.97) | Perf Year | - |
| Cash/sh | 3.6 | P/FCF | - | Sales past 3/5Y | 14.32% - | ROIC | -57.23% | 52W Low | 6.06% ($2.31) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 24.28% | Gross Margin | 81.24% | Volatility(W/M) | 13.28% 10.58% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 0.31 | Sales Y/Y TTM | 406.71% | Oper. Margin | -33.2% | ATR (14) | 0.3 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.69 | EPS Q/Q | -77.35% | Profit Margin | -72.48% | RSI (14) | 33.3 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.84 | Sales Q/Q | 80.08% | SMA20 | -9.99% ($2.72) | Beta | - | Target Price | - |
| Payout | - | Debt/Eq | 0.71 | Earnings | 2026/8/31 | SMA50 | -26.3% ($3.32) | Rel Volume | 0.01 | Prev Close | $2.62 |
| Employees | 63 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | - | SMA200 | -40.25% ($4.1) | Avg Volume(3M) | 1.43M | Price | $2.45 |
| IPO | 2026/1/21 | Option/Short | No/Yes | Trades | 216 | Volume | 17,105 | Change | -6.49% |
Company
PLSM is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🤰 PulseNmore is an Israel-based company specializing in <strong>home-use ultrasound</strong> devices, developing and selling a prenatal care platform that allows expectant mothers to easily perform ultrasound scans at home, with remote interpretation by medical professionals. The company has secured FDA De Novo approval and European CE MDR certification, and has partnered with Israel's largest HMO, <strong>Clalit</strong>, as well as Sheba Medical Center, among others, accumulating hundreds of thousands of scans. It is a small-cap stock listed on the Nasdaq and the Tel Aviv Stock Exchange.
Over the past 1 year, on the lower side
81% below its 1-year high.
PLSM has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Long-term returns are close to the market
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 7.7%.
Tap to view numbers
It ranks #4 in the industry
Based on market cap of $16M.
PLSM $16M PER -
ABT $179B PER 33.4
MDT $117B PER 22.6
SYK $104B PER 28.0
FAQ
What kind of company is PLSM?
PLSM belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of PLSM?
The market cap of PLSM is approximately $16M, ranking 5,367 within its sector.
What is the 52-week high and low for PLSM?
PLSM has recorded a 52-week high of $12.97 and a low of $2.31.
